8490
A.A. Hassan et al. / Tetrahedron 68 (2012) 8487e8492
127.3, 127.2, 126.8, 126.3, 126.0, 125.1 (AreCH), 116.1 (allyleCH2]),
66.7 (thiadiazoleeCH), 46.4 (allyleCH2N). MS (EI): m/z¼451 (Mþ,
11), 352 (8), 244 (42), 207 (26), 179 (59), 177 (100), 99 (24), 77 (26),
41 (47). Anal. Calcd for C28H25N3OS (451.58): C, 74.47; H, 5.58; N,
9.31; S, 7.10. Found: C, 74.58; H, 5.49; N, 9.18; S, 6.96.
(thiadiazoleeCH), 13.0 (CH3); MS (EI): m/z¼501 (Mþ, 11), 366 (16),
222 (31), 207 (36), 179 (100), 177 (21), 135 (52), 91 (18), 77 (28).
Anal. Calcd for C32H27N3OS (501.64): C, 76.62; H, 5.43; N, 8.38; S,
6.39. Found: C, 76.53; H, 5.51; N, 8.28; S, 6.57.
4.3.8. (2E)-1-[[2-(Pent-1-enyl)-5-(phenylamino)-1,3,4-thiadiazol-
4.3.4. (2E)-1-[2-(2-Methoxystyryl)-5-(phenylamino)-1,3,4-
thiadiazol-3(2H)-yl]-2,3-diphenyl-prop-2-en-1-one (4d). Colourless
crystals (0.371 g, 72%), mp 172e174 ꢁC (acetonitrile). IR (KBr)
3(2H)-yl]-2,3-diphenyl-prop-2-en-1-one (4h). Colourless crystals
(0.374 g, 83%), mp 143e144 ꢁC (ethanol). IR (KBr)
n
¼3310 (NH),
3070 (AreCH), 2980 (AlieCH), 1675 (CO), 1620 (C]N), 1590
(AreC]C) cmꢀ1; 1H NMR (CDCl3): dH¼7.38e7.35 (m, 4H, AreH and
NH), 7.32e7.25 (m, 5H, AreH), 7.22e7.09 (m, 6H, AreH), 6.87e6.85
(m, 2H, AreH), 6.56e6.55 (m, 1H, thiadiazoleeCH), 5.67e5.65,
5.42e5.40 (m, 2H, CH]CH), 1.97e1.95 (m, 2H, CH2), 1.32e1.30 (m,
2H, CH2), 0.85 (t, J¼7.6 Hz, 3H, CH3); 13C NMR (CDCl3): dC¼166.5
(CO), 149.0 (thiadiazole C-5), 136.3, 135.0, 134.7, 133.2 (AreC), 132.2,
128.7, 128.3, 127.9, 127.6, 127.4, 127.0, 126.7, 126.6, 125.0 (AreCH),
121.6, 117.4 (CH]CH), 67.6 (thiadiazoleeCH), 33.7 (CH2), 21.8 (CH2),
13.6 (CH3); MS (EI): m/z¼453 (Mþ, 15), 384 (38), 356 (53), 318 (54),
22 (19), 207 (36), 179 (100), 177 (62), 135 (22), 91 (16), 77 (18). Anal.
Calcd for C28H27N3OS (453.60): C, 74.14; H, 6.00; N, 9.26; S, 7.07.
Found: C, 74.22; H, 6.07; N, 9.45; S, 6.93.
n
¼3310 (NH), 3050 (AreCH), 1680 (CO), 1620 (C]N), 1600 (AreC]
C) cmꢀ1; 1H NMR (CDCl3): dH¼7.58 (br, 1H, NH), 7.40e7.07 (m, 10H,
AreH), 6.94e6.89 (m, 3H, AreH), 6.87e6.85 (m, 3H, AreH),
6.83e6.82 (m, 5H, AreH), 6.40e6.38 (m, 1H, AreH), 6.34e6.32 (m,
1H, thiadiazoleeCH), 3.79 (s, 3H, OCH3), 13C NMR (CDCl3): dC¼166.6
(CO), 156.3 (AreCeO), 156.2 (thiadiazole C-5), 136.6, 136.4, 136.2,
135.0, 134.7 (AreC), 132.7, 129.7, 128.7, 128.3, 127.9, 127.8, 127.6,
127.4, 127.2, 127.0, 126.9, 126.7, 126.6, 126.3, 125.1 (AreCH), 67.0
(thiadiazoleeCH), 54.4 (OCH3); MS (EI): m/z¼517 (Mþ, 8), 382 (26),
207 (21), 179 (177), 177 (100), 135 (24), 91 (17), 77 (26). Anal. Calcd
for C32H27N3O2S (517.64): C, 74.25; H, 5.26; N, 8.12; S, 6.19. Found: C,
74.36; H, 5.37; N, 7.97; S, 6.35.
4.3.5. (2E)-1-[5-(Benzylamino)-2-(2-methoxy-styryl)-1,3,4-
thiadiazol-3(2H)-yl]-2,3-diphenyl-prop-2-en-1-one (4e). Colourless
crystals (0.402 g, 76%), mp 177e179 ꢁC (acetonitrile). IR (KBr)
4.3.9. (2E)-1-[5-(Benzylamino)-2-(pent-1-enyl)-1,3,4-thiadiazol-
3(2H)-yl]-2,3-diphenyl-prop-2-en-1-one (4i). Colourless crystals
(0.302 g, 65%), mp 147e148 ꢁC (ethanol). IR (KBr)
3040 (AreCH), 2970 (AlieCH), 1675 (CO), 1625 (C]N), 1600
n
¼3285 (NH),
n
¼3280 (NH), 1675 (CO), 1615 (C]N), 1585 (AreC]C) cmꢀ1
;
1H
NMR (CDCl3): dH¼7.50e6.94 (m, 10H, AreH), 6.91e6.89 (m, 3H,
AreH), 6.85e6.83 (m, 4H, AreH), 6.77e6.76 (m, 4H, AreH), 6.68 (br,
1H, NH), 6.42e6.40 (m, 1H, AreH), 6.37e6.36 (m, 1H, thiadiazo-
leeCH), 3.95 (s, 2H, CH2), 3.80 (s, 3H, OCH3). 13C NMR (CDCl3):
dC¼165.7 (CO),156.3 (AreCeO),152.7 (thiadiazole C-5),136.8, 136.7,
136.6, 136.2, 135.2 (AreC), 132.6, 128.8, 128.3, 127.8, 127.6, 127.5,
127.4, 127.2, 127.0, 126.9, 126.7, 126.6, 126.5, 126.4, 125.8 (AreCH),
67.6 (thiadiazoleeCH), 54.4 (OCH3), 47.8 (CH2). MS (EI): m/z¼531
(Mþ, 9), 382 (11), 207 (16), 179 (46), 177 (36), 149 (38), 91 (100), 77
(22). Anal. Calcd for C33H29N3O2S (531.67): C, 74.55; H, 5.50; N, 7.90;
S, 6.03. Found: C, 74.73; H, 5.39; N, 8.12; S, 5.89.
(AreC]C) cmꢀ1
;
1H NMR (CDCl3): dH¼7.39e7.35 (m, 5H, AreH),
7.33e7.27 (m, 5H, AreH), 7.25e7.05 (m, 4H, AreH), 6.90e6.88 (m,
2H, AreH), 6.85 (br, 1H, NH), 6.33e6.32 (m, 1H, thiadiazoleeCH),
5.85e5.83, 5.64e5.62 (m, 2H, CH]CH), 4.10 (s, 2H, CH2), 2.05e2.07
(m, 2H, CH2), 1.38e1.39 (m, 2H, CH2), 0.84 (t, J¼7.7 Hz, 3H, CH3); 13
C
NMR (CDCl3): dC¼164.7 (CO), 149.1 (thiadiazole C-5), 136.3, 135.8,
135.1, 135.0 (AreC), 133.8, 129.6, 128.9, 127.9, 127.6, 127.0, 126.9,
126.4, 126.0, 125.8 (AreCH), 123.1, 118.3 (CH]CH), 67.8 (thiadia-
zoleeCH), 46.8 (CH2ePh), 33.8 (CH2), 20.8 (CH2), 12.6 (CH3); MS: m/
z 467 (Mþ, 12), 318 (41), 222 (28), 207 (38), 179 (100), 177 (46), 91
(12). Anal. Calcd for C29H29N3OS (467.63): C, 74.48; H, 6.25; N, 8.99;
S, 6.86. Found: C, 74.66; H, 6.31; N, 8.87; S, 7.05.
4.3.6. (2E)-1-[5-(Allylamino)-2-(2-methoxy-styryl)-1,3,4-thiadiazol-
3(2H)-yl]-2,3-diphenyl-prop-2-en-1-one (4f). Colourless crystals
4.3.10. (2E)-1-[5-(Allylamino)-2-(pent-1-enyl)-1,3,4-thiadiazol-
(0.326 g, 68%), mp 150e151 ꢁC (ethanol). IR (KBr)
n
¼3305 (NH),
3(2H)-yl]-2,3-diphenylprop-2-en-1-one (4j). Colourless crystals
3080 (AreCH), 1675 (CO), 1615 (C]N), 1580 (AreC]C) cmꢀ1 1H
;
(0.295 g, 71%), mp 126e127 ꢁC (ethanol). IR (KBr)
n
¼3305 (NH),
NMR (CDCl3): dH¼7.39e7.35 (m, 4H, AreH), 7.33e7.27 (m, 7H,
AreH), 7.22e7.05 (m, 3H, AreH), 6.90e6.88 (m, 2H, AreH), 6.28 (br,
1H, NH), 6.26e6.25 (m, 1H, thiadiazoleeCH), 6.22e6.20 (m, 1H,
AreH), 5.69e5.68 (m, 1H, allyleCH]), 5.02e5.00 (m, 2H,
3060 (AreCH), 2980 (AlieCH), 1690 (CO), 1630 (C]N), 1595
(AreC]C) cmꢀ1
;
1H NMR (CDCl3): dH¼7.37e7.30 (m, 4H, AreH),
7.25e7.18 (m, 5H, AreH), 7.15e7.00 (m, 2H, AreH), 6.36e6.35 (m,
1H, thiadiazoleeCH), 6.25 (br, 1H, NH), 6.03e6.00, 5.96e5.95,
6.00e6.03 (m, 2H, CH]CH), 5.86e5.85 (m, 1H, allyleCH]),
5.13e5.10 (m, 2H, allyleCH2]), 3.96e3.95 (m, 2H, allyleCH2N),
2.07e2.05 (m, 2H, CH2), 1.44e1.42 (m, 2H, CH2), 0.87 (t, J¼7.6 Hz,
3H, CH3); 13C NMR (CDCl3): dC¼164.7 (CO), 149.1 (thiadiazole C-5),
135.9 (allyleCH]), 135.1, 134.9 (AreC), 122.1, 118.4 (CH]CH), 129.6,
128.9, 128.3, 127.9, 127.4, 127.0, 126.1, 125.8 (AreCH), 115.9
(allyleCH2]), 66.7 (thiadiazoleeCH), 45.5 (allyleCH2N), 33.8 (CH2),
20.8 (CH2), 12.6 (CH3); MS (EI): m/z¼417 (Mþ, 8), 222 (22), 207 (28),
179 (100), 177 (42), 77 (23). Anal. Calcd for C25H27N3OS (417.57): C,
71.91; H, 6.52; N, 10.06; S, 7.68. Found: C, 72.08; H, 6.44; N, 9.93; S,
7.87.
allyleCH2]), 4.13e4.10 (m, 2H, allyleCH2N), 3.80 (s, 3H, OCH3). 13
C
NMR (CDCl3): dC¼166.7 (CO), 157.3 (AreCeO), 153.9 (thiadiazole C-
5), 135.7 (allyl-CH]), 137.6, 137.2, 136.6, 136.3, 133.6 (AreC), 133.5,
130.7, 129.8, 129.5, 129.4, 128.6, 128.3, 127.9, 127.4, 126.8, 126.2,
125.4 (AreCH), 117.1 (allyleCH2]), 68.5 (thiadiazoleeCH), 55.5
(OCH3), 47.4 (allyleCH2N). MS (EI): m/z¼481 (Mþ, 8), 382 (11), 263
(38), 207 (24), 179 (100), 177 (71), 133 (21), 99 (48), 41 (42). Anal.
Calcd for C29H27N3O2S (481.61): C, 72.32; H, 5.65; N, 8.72; S, 6.66.
Found: C, 72.46; H, 5.53; N, 8.59; S, 6.81.
4.3.7. (2E)-2,3-Diphenyl-1-[5-(phenylamino)-2-(1-phenylprop-1-en-
2-yl)-1,3,4-thiadiazol-3(2H)-yl]prop-2-ene-1-one (4g). Colourless
crystals (0.419 g, 84%), mp 166e168 ꢁC (ethanol). IR (KBr)
n
¼3310
4.3.11. (2E)-2,3-Diphenyl-1-[5-(phenylamino)-2-(prop-1-enyl)-1,3,4-
(NH), 3050 (AreCH), 1675 (CO), 1620 (C]N), 1590 (AreC]C) cmꢀ1
;
thiadiazol-3(2H)-yl]prop-2-en-1-one
(4k). Colourless
crystals
1H NMR (CDCl3): dH¼7.30e7.20 (m, 6H, AreH and NH), 7.18e7.05
(m, 10H, AreH), 7.00e6.85 (m, 6H, AreH), 6.67e6.65 (m, 1H, AreH),
6.43e6.42 (m, 1H, thiadiazoleeCH), 1.85 (s, 3H, CH3); 13C NMR
(CDCl3): dC¼168.2 (CO), 148.0 (thiadiazole C-5), 137.5, 137.1, 136.5,
136.1, 135.6, 133.5 (AreC), 133.1, 129.7, 129.4, 129.3, 129.1, 128.9,
128.8, 128.6, 128.4, 128.1, 127.8, 127.5, 126.6, 126.4 (AreCH), 67.6
(0.317 g, 75%), mp 132e133 ꢁC (ethanol). IR (KBr)
n
¼3290 (NH), 3050
(AreCH), 1675 (CO), 1630 (C]N), 1595 (AreC]C) cmꢀ1 1H NMR
;
(CDCl3): dH¼7.44 (br, 1H, NH), 7.40e7.38 (m, 3H, AreH), 7.36e7.25
(m, 8H, AreH), 7.23e7.08 (m, 3H, AreH), 6.97e6.91 (m, 2H, AreH),
6.65e6.63 (m, 1H, thiadiazoleeCH), 5.85e5.83, 5.64 (m, 2H, CH]
CH), 1.70 (d, J¼6.6 Hz, 3H, CH3); 13C NMR (CDCl3): dC¼166.5 (CO),